Velocity Clinical Research

Velocity Clinical Research not slowing down, buying two new US sites amid own acquisition

Bicoastal expansion — New York and California London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company, Velocity Clinical, regarding the additon of two new sites to its US network. Leading US-based integrated site company, Velocity Clinical Research, today announces it has… read more

GHO Capital acquires Velocity Clinical Research, signalling evolution of clinical trial site industry

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in healthcare, announces the acquisition of Velocity Clinical Research, from NaviMed Capital (“NaviMed”) and other investors, signalling how the business of running clinical trial sites is changing. Headquartered in Durham, North Carolina, Velocity operates 16 fully-owned sites across 11 US… read more

Subscribe to our email alerts

Email updates